That’s my belief when it comes to recognizing conspiracies. All you have to do is look closely, think a little and if they’re there they become obvious. Especially when the news man has a slip of the tongue…
Furthermore, VAERS transmits its vaccine adverse event reports to the Uppsala Monitoring Center, the World Health Organization collaborating center for international drug and vaccine safety monitoring [4,5], in order to contribute to the global pharmacovigilance effort along with other countries that employ passive vaccine safety monitoring systems…
…It turns out that Viscount Ridley’s line of questioning was correct all along. The Uppsala adaptation of Ferguson’s model not only projected exaggerated death tolls in Sweden. Ferguson’s own projections for Sweden advanced similar numbers, all wildly off the mark from what happened.
and closed with this…
Just over one year ago, the epidemiology modeling of Neil Ferguson and Imperial College played a preeminent role in shutting down most of the world. The exaggerated forecasts of this modeling team are now impossible to downplay or deny, and extend to almost every country on earth. Indeed, they may well constitute one of the greatest scientific failures in modern human history.
Seemed a straight-a-way conspiracy right there but further information made this mystery story’s complexities more bizarre.
Do you remember Peter Thiel, the Facebook/PayPal kazillionaire guy who walked away from that money fountain and invented Palantir, the super-secret specializer of big data analytics?
I came across a story today dated April 2 that at first seemed like icing on the cake regarding the likely conspiracy connections in the VAERS-WHO-Imperial college story.
But after reading the Guardian story it looks like the icing is rainbow stained and intended for an upside down cake center-piece for a surprise party you won’t believe for the rest of your life.
Oh, and don’t think that hand extended to you after the surprise party is there to help.
Antibody gene transfer, which involves the delivery of genes that encode potent, broadly neutralizing anti-HIV antibodies, is a promising new strategy to prevent HIV infection. A satellite symposium at the AIDS Vaccine 2012 conference brought together many of the groups working in this field.
Despite nearly thirty years of intense study, efforts to develop a safe and effective HIV vaccine by conventional means have either failed or provided only modest, short-lived protection. While the tantalizing results of the HIV vaccine trial RV144 in Thailand continue to guide efforts to improve the efficacy and duration of a vaccine that harnesses the natural immune system, it remains uncertain when or if such efforts will succeed…
…Antibody gene transfer is a novel protective strategy that bypasses the natural immune response, which has been the central focus of previous attempts to develop an HIV vaccine, by directing the production of antibodies from non-hematopoietic tissues, such as muscle (Figure 1). Because this approach skips many of the steps in the usual path of vaccine development, it has been described as a leapfrog strategy. Recent advances in the use of gene transfer for the correction of genetic deficiencies…3,4 …have bolstered the intriguing possibility of utilizing adeno-associated virus (AAV) vectors as a vehicle for antibody gene delivery in humans. Two recent studies have demonstrated the feasibility of this approach against both SIV in macaques5 as well as HIV in humanized mice6…
As the worldwide human antibody gene transfer experiments continue on, what they who are behind it fail to share with the public in their coercive propaganda programming is their decades old documented scientific history; a history that openly acknowledges bypassing the natural immune system results in complexities that turn their planned implanted nano-control knob into a long term T-1000 type detour.
After learning that the results of two studies were reason enough for modern science poohbahs to abandon their previously established and rigorously defended method of ‘harnessing the natural immune system’, it occurred to me documentation of the results of efforts of the new vaxx technocrats might be a helpful clarification for the purposely misguided, thus enabling parity for the UNdereducated public who are embracing the built in mediocrity of the ‘go along to get along’ philosophy the https://lasd.org/operation-homebound army of the mundane enforces; that is, a parity with the mask-less who had no problem detecting the grievous opprobrium of the weightless political stench early on in this power grab.
Gene replacement therapy represents an interesting new approachfor the treatment of cystic fibrosis (CF) lungdisease. Basic research suggests that CF gene therapy is feasible, but major technological challenges must be addressed before clinical applications are likely to succeed…
Conclusion Although topical gene transfer to the airways for CF gene therapy is more challenging than originally thought, significant progress has been made in pre-clinical research over the last 2 years to overcome some of the hurdles.
Most importantly, the identification of more effective viral and non-viral gene transfer agents for airway gene delivery, development of new delivery routes and most recently alternative strategies are keeping the development of CF gene therapy well on track.
Over the last decade, it became apparent that gene transfer to the AECs is difficult. This is perhaps unsurprising, given the lung has evolved to keep foreign particles out. The major obstacle for most viral GTAs is the effective immune surveillance mechanisms in the lung, which prohibit repeat administration. Many strategies to overcome this problem have already been explored, but have not yet been successful. In our view, this may be a difficult hurdle to overcome.
Non-viral gene transfer has traditionally been inefficient, but recently developed nanoparticles and ligand-targeting appear to be overcoming this problem. Importantly, physical delivery methods to increase non-viral gene transfer are currently being assessed in the lung. Although gene therapy for CF is not yet a clinical reality, the many innovative strategies currently being assessed should lead to efficient and repeatable airway gene transfer within the next few years.
At the turn of the century, the field of gene therapy saw a significant erosion of support for a variety of reasons (Wilson, 2009). Despite extensive clinical trial activity, the field had no clear demonstration of clinical success. My assessment was that available vector technology was not suitable for most of the clinical applications that were contemplated. I approached Tachi Yamada, who at the time was chief scientific officer of SmithKlineBeecham (SB), for advice about the current state of the field and what I could do to move it forward. Tachi was the chair of my department at Michigan and a very important mentor. He encouraged me to “go back to the bench” and focus on creating better vectors and offered to have SB help support this effort through a sizable sponsored research agreement with Penn. We had the financial support—we now needed a plan!
The warning comes amidst a scramble by three companies—Sarepta Therapeutics, Pfizer, and Solid Biosciences—to be the first to use the technique to cure muscular dystrophy. That disease strikes young boys, destroys their muscles, and kills them by their 20s.
Squinto was astounded. “He runs his gene therapy center like you’d run a very efficient company,” he thought. With Wilson’s infrastructure and decades of know-how, any spin-off company financed by Squinto’s firm could hit the ground running. “It’s all here,” he told Wilson. “And I’m willing to pay for it.”
Over the next few months, the duo negotiated an intimate arrangement: they would form a new company, and Wilson’s lab at Penn would function as its R&D arm…
…The importance of the cystic fibrosis gene discovery went far beyond a single illness. It helped build the case for the $3 billion project to sequence the entire human genome, which would alter understanding of human biology and shed light on rare and common diseases.
But the story of cystic fibrosis has been illustrative in a way that no one could have anticipated back then. In the early days of human genetics, the path seemed straightforward: Find the gene, fix the gene and repeat for other diseases. The cystic fibrosis journey, from an exuberant moment of insight to a major success, would take 30 years of persistent, methodical work: a feat of science, business, fundraising and patience that has become a model for other diseases.
Gene therapy has been around for quite a while now, a couple decades in some places. My point is, it’s not been a complete success so far. Anywhere. We are being hustled into accepting this covid-19 assault based on a ‘therapy’ that has been mired in disappointment, distortion and disgrace for most of its existence. Who could ask for a better setting for the birth of a new world order?
Safety monitoring in the Vaccine Adverse Event Reporting System
Abstract
The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) conduct post-licensure vaccine safety monitoring using the Vaccine Adverse Event Reporting System (VAERS), a spontaneous (or passive) reporting system. This means that after a vaccine is approved, CDC and FDA continue to monitor safety while it is distributed in the marketplace for use by collecting and analyzing spontaneous reports of adverse events that occur in persons following vaccination…
Generally, VAERS data cannot be used to determine if a vaccine caused an adverse event. VAERS data interpreted alone or out of context can lead to erroneous conclusions about cause and effect as well as the risk of adverse events occurring following vaccination. CDC makes VAERS data available to the public and readily accessible online…
Introduction
…CDC and FDA co-administer the Vaccine Adverse Event Reporting System (VAERS), a spontaneous (or passive) reporting system [1]. Spontaneous surveillance means that no active effort is made to search for, identify and collect information, but rather information is passively received from those who choose to voluntarily report their experience. Therefore, VAERS relies on the intuition and experience of healthcare professionals in particular, but likewise for patients, parents and caregivers, to recognize and report unusual or unexpected events following vaccination or suspected vaccine safety problems. CDC and FDA also independently administer large-linked electronic health record-based surveillance systems [2,3]. Various methods and statistical techniques are used to analyze VAERS data, which CDC and FDA use to guide further safety evaluations and inform decisions around vaccinerecommendations and regulatory action.
Furthermore, VAERS transmits its vaccine adverse event reports to the Uppsala Monitoring Center, the World Health Organization collaborating center for international drug and vaccine safety monitoring [4,5], in order to contribute to the global pharmacovigilance effort along with other countries that employ passive vaccine safety monitoring systems. VAERS data must be interpreted with caution due to the inherent limitations of passive surveillance. VAERS is primarily a safety signal detection and hypothesis generating system…
Do you really think, based on the amount of information provided above, ‘medical/scientific’ protocol has ever been followed in this covert covid war?
With all this scientific background fresh in your mind along with the awareness of the role computer monitoring systems played in the stolen election consider a couple of questions based on the following video presentation?
Do you think the John Malkovich characterization of Lennie Small is a fair representation of Nancy Pelosi’s alleged stated opinion of American citizens level of mental acuity?
If you do, who or what do you think Gary Sinese characterization of George Milton would represent in this war they publicly declared on covid that actually targets US?
There is only so much left to be said about this Covid-19 based scamdemic and in my opinion, Dr. Ryan Cole, the CEO and Medical Director of Cole Diagnostics can close the medical discussion out with a mix of common sense, medical wisdom and legal familiarity.
…Dr. Cole is a Mayo Clinic trained Board Certified Pathologist. He is Board Certified in anatomic and clinical pathology. He has expertise in immunology and virology and also has subspecialty expertise in skin pathology. He has seen over 350,000 patients in his career, and has done over 100,000 Covid tests in the past year. He recently was invited to speak at the “Capitol Clarity” event in Idaho… where he discussed successful outpatient treatments for COVID, and to offer his views on the new COVID “vaccines.”
